tiprankstipranks
Trending News
More News >
J Frontier Co., Ltd. (JP:2934)
:2934
Japanese Market
Advertisement

J Frontier Co., Ltd. (2934) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2934

J Frontier Co., Ltd.

(2934)

Rating:44Neutral
Price Target:
¥1,764.00
▲(4.38%Upside)
The stock's overall score is primarily impacted by its financial performance challenges, with significant profitability and cash flow issues. Despite some positive technical indicators suggesting short-term momentum, the poor valuation due to lack of profitability and dividends significantly lowers the score.

J Frontier Co., Ltd. (2934) vs. iShares MSCI Japan ETF (EWJ)

J Frontier Co., Ltd. Business Overview & Revenue Model

Company DescriptionJ Frontier Co., Ltd. is a Japan-based company primarily engaged in the healthcare and beauty sectors. The company offers a range of products and services that include online medical consultations, health-related e-commerce, and other digital healthcare solutions. J Frontier Co., Ltd. leverages technology to bridge the gap between consumers and healthcare providers, facilitating access to medical and wellness products.
How the Company Makes MoneyJ Frontier Co., Ltd. generates revenue through multiple streams. Firstly, the company earns money from its e-commerce platform, which sells a variety of health and beauty products directly to consumers. Additionally, the company provides online medical consultation services, where it charges fees for virtual appointments and related healthcare services. The company also partners with healthcare providers and pharmaceutical companies to expand its service offerings and improve its product range. Furthermore, J Frontier Co., Ltd. may receive revenue from advertising or promotional partnerships on its platforms, contributing to its overall earnings.

J Frontier Co., Ltd. Financial Statement Overview

Summary
J Frontier Co., Ltd. shows revenue growth but faces profitability and cash flow challenges. Increasing leverage heightens financial risk, and negative cash flows suggest operational inefficiencies. Improvement in profitability and cash flow generation is critical for financial stability.
Income Statement
45
Neutral
The company has shown revenue growth over the years, with a notable increase from 2022 to 2023. However, the profitability metrics such as EBIT and net income have been negative in recent years, indicating operational challenges. The gross profit margin has remained fairly stable, but negative EBIT and EBITDA margins suggest significant costs impacting earnings.
Balance Sheet
40
Negative
The debt-to-equity ratio has increased, indicating higher leverage, which poses a risk if earnings do not improve. Although the equity ratio has decreased, the company still maintains a positive stockholder equity, suggesting some balance sheet resilience. However, the declining ROE reflects inefficiencies in generating returns from equity.
Cash Flow
35
Negative
The company has struggled with negative operating and free cash flows, indicating cash generation issues. The free cash flow has not shown improvement, and the operating cash flow to net income ratio is negative, highlighting challenges in converting profits into cash. While financing activities have provided some relief, reliance on external funding is not sustainable long-term.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue17.71B16.84B11.88B8.49B7.11B
Gross Profit8.33B7.12B5.40B6.63B5.49B
EBITDA-1.22B-1.54B760.66M706.10M237.16M
Net Income-2.09B-1.90B400.52M424.93M96.37M
Balance Sheet
Total Assets10.71B7.24B6.10B2.59B2.03B
Cash, Cash Equivalents and Short-Term Investments1.81B1.65B2.96B1.64B908.06M
Total Debt5.17B2.14B546.79M75.21M168.86M
Total Liabilities9.09B4.53B1.94B1.33B1.19B
Stockholders Equity1.15B2.48B4.14B1.27B842.76M
Cash Flow
Free Cash Flow-1.54B-1.94B-377.40M823.99M213.16M
Operating Cash Flow-1.44B-1.83B-366.94M830.91M218.30M
Investing Cash Flow-1.79B-1.13B-860.09M-7.99M-165.10M
Financing Cash Flow3.39B1.45B2.56B-93.65M-99.10M

J Frontier Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1690.00
Price Trends
50DMA
1712.94
Negative
100DMA
1789.05
Negative
200DMA
1741.94
Negative
Market Momentum
MACD
-34.01
Positive
RSI
48.98
Neutral
STOCH
90.85
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Neutral. The current price of 1690 is below the 20-day moving average (MA) of 1719.25, below the 50-day MA of 1712.94, and below the 200-day MA of 1741.94, indicating a bearish trend. The MACD of -34.01 indicates Positive momentum. The RSI at 48.98 is Neutral, neither overbought nor oversold. The STOCH value of 90.85 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2934.

J Frontier Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥20.05B18.31
2.04%12.51%9.68%
76
Outperform
¥261.39B43.83
0.41%28.85%26.67%
73
Outperform
¥11.97B23.96
2.44%9.21%-20.04%
72
Outperform
¥20.91B21.35
1.47%17.20%20.25%
51
Neutral
$7.38B0.34-69.01%2.37%16.35%0.39%
44
Neutral
¥8.82B97.09
31.42%34.01%
43
Neutral
¥19.65B4,465.71
1.26%-7.98%-181.00%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2934
J Frontier Co., Ltd.
1,690.00
522.00
44.69%
JP:3649
FINDEX Inc.
783.00
-138.65
-15.04%
JP:3902
Medical Data Vision Co.Ltd.
504.00
74.50
17.35%
JP:3939
Kanamic Network Co., LTD.
441.00
-9.56
-2.12%
JP:4320
CE Holdings Co., Ltd.
720.00
363.76
102.11%
JP:4483
JMDC Inc.
3,998.00
949.06
31.13%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 05, 2025